FEATURED COMPANIES
- Abbott Laboratories
- Bolton Medical
- CR BARD
- Endologix
- JOTEC
- Marizyme, Inc.
Vascular Grafts Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global vascular grafts market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the vascular grafts? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Vascular grafts market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider vascular grafts market, and compares it with other markets.
The report covers the following chapters:
Product/Service Analysis - The product/service analysis section of the report describes the leading products/services in the vascular grafts market along with key features and differentiators for those products/services.
Scope
Markets Covered:
1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Peripheral Vascular Grafts; Coronary Artery By-pass Grafts
2) By Raw Material: Polyester Grafts; Polytetrafluoroethylene Grafts; Polyurethane Grafts; Biosynthetic Grafts
3) By Application: Coronary Artery Disease; Aneurysm; Vascular Occlusion; Renal Failure
4) By End-User: Hospitals; Ambulatory Surgical Centers
Companies Mentioned: B. Braun Melsungen AG; Abbott Laboratories; Becton, Dickinson and Company; Cardinal Health, Inc.; W. L. Gore & Associates, Inc.
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, vascular grafts indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for the vascular grafts? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Vascular grafts market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider vascular grafts market, and compares it with other markets.
The report covers the following chapters:
- Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
- Report Structure - This section gives the structure of the report and the information covered in the various sections.
- Market Characteristics - The market characteristics section of the report defines and explains the vascular grafts market. This chapter also defines and describes goods and related services covered in the report.
Product/Service Analysis - The product/service analysis section of the report describes the leading products/services in the vascular grafts market along with key features and differentiators for those products/services.
- Customer Information - This chapter covers recent customers’ trends/preferences in the global vascular grafts market.
- Trends and Strategies - This chapter describes the major trends shaping the global vascular grafts market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- Global Market Size and Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
- Segmentation - This section contains the market values (2015-2030) and analysis for different segments.
- Global Macro Comparison - The global vascular grafts market comparison with macro-economic factors gives the vascular grafts market size, percentage of GDP, and average vascular grafts market expenditure.
- Regional Market Size and Growth - This section contains the region’s market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
- Competitive Landscape - This section covers details on the competitive landscape of the global vascular grafts market, estimated market shares and company profiles for the leading players.
- Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Market Opportunities and Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Conclusions and Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for vascular grafts companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Peripheral Vascular Grafts; Coronary Artery By-pass Grafts
2) By Raw Material: Polyester Grafts; Polytetrafluoroethylene Grafts; Polyurethane Grafts; Biosynthetic Grafts
3) By Application: Coronary Artery Disease; Aneurysm; Vascular Occlusion; Renal Failure
4) By End-User: Hospitals; Ambulatory Surgical Centers
Companies Mentioned: B. Braun Melsungen AG; Abbott Laboratories; Becton, Dickinson and Company; Cardinal Health, Inc.; W. L. Gore & Associates, Inc.
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, vascular grafts indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Bolton Medical
- CR BARD
- Endologix
- JOTEC
- Marizyme, Inc.
1. Vascular Grafts Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction
7. Vascular Grafts Market Characteristics
8. Vascular Grafts Market Trends and Strategies
9. Impact Of COVID-19 On The Vascular Grafts Market
10. Global Vascular Grafts Market Size and Growth
11. Global Vascular Grafts Market Segmentation
12. Vascular Grafts Market, Regional and Country Analysis
13. Asia-Pacific Vascular Grafts Market
14. Western Europe Vascular Grafts Market
15. Eastern Europe Vascular Grafts Market
16. North America Vascular Grafts Market
17. South America Vascular Grafts Market
18. Middle East Vascular Grafts Market
19. Africa Vascular Grafts Market
20. Vascular Grafts Market, Competitive Landscape
21. Key Mergers and Acquisitions In The Vascular Grafts Market
22. Vascular Grafts Market Opportunities and Strategies
23. Vascular Grafts Market, Conclusions and Recommendations
24. Appendix
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Bolton Medical
- CR BARD
- Endologix
- JOTEC
- Marizyme, Inc.
This report describes and explains the global vascular grafts market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.
The global vascular grafts market reached a value of nearly $2,595.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 2.4% since 2015. The market is expected to grow from $2,595.3 million in 2020 to $3,377.2 million in 2025 at a rate of 5.4%. The market is then expected to grow at a CAGR of 4.3% from 2025 and reach $4,169.0 million in 2030.
Growth in the historic period in the vascular grafts market resulted from increase in cardiovascular diseases (CVDs), increased geriatric population, strong economic growth in emerging markets, rise in healthcare expenditure and growth in the number of healthcare facilities. The market was restrained by high costs of surgery and low healthcare access.
Going forward increasing number of renal diseases, increase in hypertension prevalence, sedentary lifestyles, rapid growth in the geriatric population, increase in diabetes, increase in cardiovascular diseases (CVDs) and rise in healthcare expenditure will drive the growth in the vascular grafts market. Factors that could hinder the growth of the market in the future include complications associated with vascular grafts, the coronavirus pandemic and low per capita healthcare expenditure.
The vascular grafts market is segmented by product into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts and coronary artery by-pass grafts. The endovascular stent graft market was the largest segment of the vascular grafts market segmented by product, accounting for 75.6% of the total in 2020. Going forward, the endovascular stent grafts segment is expected to be the fastest growing segment in the vascular grafts market segmented by product, at a CAGR of 5.7% during 2020-2025.
The vascular grafts market is also segmented by raw material into polytetrafluoroethylene grafts, biosynthetic grafts, polyester grafts and polyurethane grafts. The polytetrafluoroethylene grafts market was the largest segment of the vascular grafts market segmented by raw material, accounting for 53.0% of the total in 2020. Going forward, the polytetrafluoroethylene grafts segment is expected to be the fastest growing segment in the proteomic services market segmented by raw material, at a CAGR of 5.5% during 2020-2025.
The vascular grafts market is also segmented by application into aneurysm, vascular occlusion, renal failure and coronary artery disease. The aneurysm market was the largest segment of the vascular grafts market segmented by application, accounting for 69.5% of the total in 2020. Going forward, the aneurysm segment is expected to be the fastest growing segment in the vascular grafts market segmented by application, at a CAGR of 5.7% during 2020-2025.
The vascular grafts market is also segmented by end-user into hospitals and ambulatory surgical centers. The hospitals market was the largest segment of the vascular grafts market segmented by end-user, accounting for 89.6% of the total in 2020. Going forward, the hospitals segment is expected to be the fastest growing segment in the vascular grafts market segmented by end-user, at a CAGR of 5.4% during 2020-2025.
North America was the largest region in the global vascular grafts market, accounting for 34.6% of the total in 2020. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the vascular grafts market will be Middle East and Africa where growth will be at CAGRs of 8.7% and 8.4% respectively. These will be followed by South America and Asia-Pacific, where the markets are expected to register CAGRs of 7.6% and 6.4% respectively.
The coronavirus pandemic caused a global economic slowdown and impacted various industries across the world, including the vascular grafts market. Nationwide lockdowns and restrictions on activity to contain COVID-19 are disrupting supply chains and affecting manufacturing worldwide. The pandemic has caused significant disruptions in the delivery of healthcare services worldwide. Vascular patients are usually under high risk for respiratory compromise and subsequent mortality if they contract COVID-19. The patient pool is often frail, elderly, comorbid, and they have less respiratory and physiological reserve than many others who contract the SARS-CoV2 virus. The reallocation of intensive care resources, such as ventilators has impacted cardiac surgeries. Also, the elective cardiac surgeries have been delayed owing to the redistribution of intensive care resources and the inherent risk of patients with comorbidities acquiring COVID‐19, mainly due to factors such as prolonged hospital admission, the invasive nature of certain procedures, aerosol-generating nature of procedures, and due to the decreased potential of ICU resources. The medical facilities are being used to treat patients suffering from Covid-19 and hence there is decrease in the intensive care capacity. In April 2020, in the Lombardy region of Italy, 16 out of 20 cardiac surgical units discontinued services and the urgent cases were shifted to remaining four units for centralized services.
The vascular grafts market is highly concentrated with small number oflarge players holding significant market share. The top ten competitors in the market made up to 65.68% of the total market in 2019. Major players in the market include B. Braun Melsungen AG, Abbott Laboratories, Becton, Dickinson And Company, Cardinal Health, Inc., W. L. Gore & Associates, Inc., Terumo Medical Corporation, Medtronic Plc, Getinge, Endologix and Cook Medical.
The top opportunities in the vascular grafts market segmented by product will arise in the endovascular stent grafts segment, which will gain $626.8 million of global annual sales by 2025. The top opportunities in the vascular grafts market segmented by raw material will arise in the polytetrafluoroethylene grafts segment, which will gain $421.0 million of global annual sales by 2025. The top opportunities in the vascular grafts market segmented by application will arise in the aneurysm segment, which will gain $573.7 million of global annual sales by 2025. The top opportunities in the vascular grafts market segmented by end-user will arise in the hospitals segment, which will gain $706.2 million of global annual sales by 2025. The vascular grafts market size will gain the most in the USA at $142.5 million.
Market-trend-based strategies for the vascular grafts market include investing in the latest technology for improving the compliance with smaller vascular grafts, investing in technology such as 3D cell printing, for greater safety and ultimately higher success rates, investing in cell-free vascular grafts, investing in monitoring technology such as smart patches or self-monitoring devices and investing in research and development for newer and more innovative solutions to improve patient care.
Player-adopted strategies in the vascular grafts market include product and process innovations, development of innovative products through sustainable investments in research and development, expanding product portfolio through acquiring similar companies, expanding business and operational presence through product launches and business expansion through partnerships and collaborations.
To take advantage of the opportunities, the publisher recommends the vascular grafts companies to focus on small caliber compliant vascular grafts, invest in manufacturing 3d printed vascular grafts, focus on collaborations to develop new products, expand in emerging markets, provide competitively priced offerings, companies should focus on increasing awareness on importance of early diagnosis of cardiovascular diseases, educating healthcare professionals, focus on patients suffering from cardiovascular diseases.
The global vascular grafts market reached a value of nearly $2,595.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 2.4% since 2015. The market is expected to grow from $2,595.3 million in 2020 to $3,377.2 million in 2025 at a rate of 5.4%. The market is then expected to grow at a CAGR of 4.3% from 2025 and reach $4,169.0 million in 2030.
Growth in the historic period in the vascular grafts market resulted from increase in cardiovascular diseases (CVDs), increased geriatric population, strong economic growth in emerging markets, rise in healthcare expenditure and growth in the number of healthcare facilities. The market was restrained by high costs of surgery and low healthcare access.
Going forward increasing number of renal diseases, increase in hypertension prevalence, sedentary lifestyles, rapid growth in the geriatric population, increase in diabetes, increase in cardiovascular diseases (CVDs) and rise in healthcare expenditure will drive the growth in the vascular grafts market. Factors that could hinder the growth of the market in the future include complications associated with vascular grafts, the coronavirus pandemic and low per capita healthcare expenditure.
The vascular grafts market is segmented by product into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts and coronary artery by-pass grafts. The endovascular stent graft market was the largest segment of the vascular grafts market segmented by product, accounting for 75.6% of the total in 2020. Going forward, the endovascular stent grafts segment is expected to be the fastest growing segment in the vascular grafts market segmented by product, at a CAGR of 5.7% during 2020-2025.
The vascular grafts market is also segmented by raw material into polytetrafluoroethylene grafts, biosynthetic grafts, polyester grafts and polyurethane grafts. The polytetrafluoroethylene grafts market was the largest segment of the vascular grafts market segmented by raw material, accounting for 53.0% of the total in 2020. Going forward, the polytetrafluoroethylene grafts segment is expected to be the fastest growing segment in the proteomic services market segmented by raw material, at a CAGR of 5.5% during 2020-2025.
The vascular grafts market is also segmented by application into aneurysm, vascular occlusion, renal failure and coronary artery disease. The aneurysm market was the largest segment of the vascular grafts market segmented by application, accounting for 69.5% of the total in 2020. Going forward, the aneurysm segment is expected to be the fastest growing segment in the vascular grafts market segmented by application, at a CAGR of 5.7% during 2020-2025.
The vascular grafts market is also segmented by end-user into hospitals and ambulatory surgical centers. The hospitals market was the largest segment of the vascular grafts market segmented by end-user, accounting for 89.6% of the total in 2020. Going forward, the hospitals segment is expected to be the fastest growing segment in the vascular grafts market segmented by end-user, at a CAGR of 5.4% during 2020-2025.
North America was the largest region in the global vascular grafts market, accounting for 34.6% of the total in 2020. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the vascular grafts market will be Middle East and Africa where growth will be at CAGRs of 8.7% and 8.4% respectively. These will be followed by South America and Asia-Pacific, where the markets are expected to register CAGRs of 7.6% and 6.4% respectively.
The coronavirus pandemic caused a global economic slowdown and impacted various industries across the world, including the vascular grafts market. Nationwide lockdowns and restrictions on activity to contain COVID-19 are disrupting supply chains and affecting manufacturing worldwide. The pandemic has caused significant disruptions in the delivery of healthcare services worldwide. Vascular patients are usually under high risk for respiratory compromise and subsequent mortality if they contract COVID-19. The patient pool is often frail, elderly, comorbid, and they have less respiratory and physiological reserve than many others who contract the SARS-CoV2 virus. The reallocation of intensive care resources, such as ventilators has impacted cardiac surgeries. Also, the elective cardiac surgeries have been delayed owing to the redistribution of intensive care resources and the inherent risk of patients with comorbidities acquiring COVID‐19, mainly due to factors such as prolonged hospital admission, the invasive nature of certain procedures, aerosol-generating nature of procedures, and due to the decreased potential of ICU resources. The medical facilities are being used to treat patients suffering from Covid-19 and hence there is decrease in the intensive care capacity. In April 2020, in the Lombardy region of Italy, 16 out of 20 cardiac surgical units discontinued services and the urgent cases were shifted to remaining four units for centralized services.
The vascular grafts market is highly concentrated with small number oflarge players holding significant market share. The top ten competitors in the market made up to 65.68% of the total market in 2019. Major players in the market include B. Braun Melsungen AG, Abbott Laboratories, Becton, Dickinson And Company, Cardinal Health, Inc., W. L. Gore & Associates, Inc., Terumo Medical Corporation, Medtronic Plc, Getinge, Endologix and Cook Medical.
The top opportunities in the vascular grafts market segmented by product will arise in the endovascular stent grafts segment, which will gain $626.8 million of global annual sales by 2025. The top opportunities in the vascular grafts market segmented by raw material will arise in the polytetrafluoroethylene grafts segment, which will gain $421.0 million of global annual sales by 2025. The top opportunities in the vascular grafts market segmented by application will arise in the aneurysm segment, which will gain $573.7 million of global annual sales by 2025. The top opportunities in the vascular grafts market segmented by end-user will arise in the hospitals segment, which will gain $706.2 million of global annual sales by 2025. The vascular grafts market size will gain the most in the USA at $142.5 million.
Market-trend-based strategies for the vascular grafts market include investing in the latest technology for improving the compliance with smaller vascular grafts, investing in technology such as 3D cell printing, for greater safety and ultimately higher success rates, investing in cell-free vascular grafts, investing in monitoring technology such as smart patches or self-monitoring devices and investing in research and development for newer and more innovative solutions to improve patient care.
Player-adopted strategies in the vascular grafts market include product and process innovations, development of innovative products through sustainable investments in research and development, expanding product portfolio through acquiring similar companies, expanding business and operational presence through product launches and business expansion through partnerships and collaborations.
To take advantage of the opportunities, the publisher recommends the vascular grafts companies to focus on small caliber compliant vascular grafts, invest in manufacturing 3d printed vascular grafts, focus on collaborations to develop new products, expand in emerging markets, provide competitively priced offerings, companies should focus on increasing awareness on importance of early diagnosis of cardiovascular diseases, educating healthcare professionals, focus on patients suffering from cardiovascular diseases.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- B. Braun Melsungen AG
- Abbott Laboratories
- Becton, Dickinson And Company
- Cardinal Health, Inc.
- W. L. Gore & Associates, Inc.
- Terumo Medical Corporation
- Medtronic Plc
- Getinge
- Endologix
- Cook Medical
- MicroPort
- CR BARD
- Biovic
- Creganna
- Novomed Incorporation Private Limited
- Marizyme, Inc.
- LeMaitre Vascular
- Olympus Medical Systems Corporation
- Japan Lifeline
- Terumo Corporation
- JOTEC
- Vascutek
- RUA Life Sciences
- Vascular Flow Technologies
- Bolton Medical
- Kips Bay Medical Incorporated
- Cryolife
- Marcus Medical
Note: Product cover images may vary from those shown
LOADING...